Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance
Drug Resistance Updates · 2024
DOI: 10.1016/j.drup.2024.101066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2024. Verfasst von Tomoka Gose und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: ATP-Binding Cassette Transporters, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
ABCG2 is an important ATP-binding cassette transporter impacting the absorption and distribution of over 200 chemical toxins and drugs. ABCG2 also reduces the cellular accumulation of diverse chemotherapeutic agents. Acquired somatic mutations in the phylogenetically conserved amino acids of ABCG2 might provide unique insights into its molecular mechanisms of transport. Here, we identify a tumor-derived somatic mutation (Q393K) that occurs in a highly conserved amino acid across mammalian species. This ABCG2 mutant seems incapable of providing ABCG2-mediated drug resistance. This was perplexing because it is localized properly and retained interaction with substrates and nucleotides. Using a conformationally sensitive antibody, we show that this mutant appears "locked" in a non-functional conformation. Structural modeling and molecular dynamics simulations based on ABCG2 cryo-EM structures suggested that the Q393K interacts with the E446 to create a strong salt bridge. The salt bridge is proposed to stabilize the inward-facing conformation, resulting in an impaired transporter that lacks the flexibility to readily change conformation, thereby disrupting the necessary communication between substrate binding and transport.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
- Theoretical and Computational Biophysics Group, NIH Center for Macromolecular Modeling and Visualization, Beckman Institute for Advanced Science and Technology, Department of Biochemistry, and Center for Biophysics and…
- School of Biological Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. Electronic address: john.schuetz@stjude.org.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Gose, T., Rasouli, A., Dehghani-Ghahnaviyeh, S., Wen, P. C., Wang, Y., Lynch, J., Fukuda, Y., Shafi, T., Ford, R. C., Tajkhorshid, E., & Schuetz, J. D. (2024). Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2024.101066
Vancouver
Gose T, Rasouli A, Dehghani-Ghahnaviyeh S, Wen PC, Wang Y, Lynch J, et al. Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance. Drug Resistance Updates. 2024. doi:10.1016/j.drup.2024.101066
BibTeX
@article{Gose2024,
author = {Gose, Tomoka and Rasouli, Ali and Dehghani-Ghahnaviyeh, Sepehr and Wen, Po-Chao and Wang, Yao and Lynch, John and Fukuda, Yu and Shafi, Talha and Ford, Robert C and Tajkhorshid, Emad and Schuetz, John D},
title = {Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance},
journal = {Drug Resistance Updates},
year = {2024},
doi = {10.1016/j.drup.2024.101066}
}
EUVIMED